Sponsored By

Merck Temporarily Suspends Sales of Zilmax™

Merck announces that it will temporarily suspend the sales of its beta-agonist Zilmax in the U.S. and Canada to conduct a scientific audit. Earlier in the week, Merck pledged to implement a "Five step plan to responsible beef."

August 16, 2013

1 Min Read
Merck Temporarily Suspends Sales of Zilmax™

Citing its commitment to helping producers use Zilmax™ responsibly, Merck Animal Health announced Aug. 16 that it would temporarily suspend sales of its beta-agonist zilpaterol hydrochloride in the U.S. and Canada. Merck earlier pledged to implement a “Five step plan to responsible beef,” committing to conducting scientific audit and recertifying every feeder, nutritionist and veterinarian authorized to feed the popular additive. This all comes as a response to Tyson's announcement last week that it would no longer buy Zilmax-fed cattle after Sept. 6.

According to a statement, suspending sales will allow the company sufficient time for the establishment of valid study protocols, identification of feeders and packers to participate in the audit, and creation of a third-party team to oversee this process and validate its results.

Read more about Merck's decision to suspend sales here.


You might also like:

3 Tips For Increased Beef Cow Profits

Jamie Oliver Says McDonald's Burgers Unfit For Human Consumption

Monthly Outlook: Frustrating Cattle Market Shows Positive Signs

Product Update: 13 New Tractors For Your Ranch

Tyson Says It Wont Buy Zilmax-Fed Cattle After Sept 6

Subscribe to Our Newsletters
BEEF Magazine is the source for beef production, management and market news.

You May Also Like